Dr Silvia Secco is a full member of staff at Urologic Clinic, Niguarda Hospital in Milan, where the Retzius-sparing approach for radical robotic prostatectomy has been conceived.
She moved to Milan after graduating and finishing her residency at the University of Padua.
She has extensive surgical experience as the first surgeon in Robotic, Endoscopic and Laparoscopic Urological Surgery.
She is also passionate about functional urology and mini-invasive treatments for LUTS since the very beginning of her residency.
She is an active member in several Urological Associations (EAU, AUA, SIU, SIUD, AURO).
She is the Author of more than 50 scientific papers published in peer-reviewed impact-factored scientific journals with a Scopus H-index of 18 and more than 3000 citations.
Selected publications from PubMed
HypnoVR®in minimally invasive surgical techniques (MISTs) for lower urinary tract symptoms (LUTS): a safe, sedation-reducing tool improving patient experience.
Olivero A, Giudici S, Caviglia A, Palagonia E, Nizzardo M, Quistini A, Grasso A, Maltzman O, Colombo M, Tappero S, Mazzone E, Dell'Oglio P, Bocciardi AM, Galfano A, Secco S
Can J Urol. 2026 Aug 21;33(4):959-965 doi: 10.32604/cju.2026.076804.
Functional outcomes and retreatment rates after iTIND implantation in a real-world Italian multicenter cohort: the importance of patient selection.
Cindolo L, Olivero A, Vittori G, Gallo F, Lambertini L, Castellucci R, Salvaggio MD, Turbanti A, Piccolotti D, Lombardo R, De Nunzio C, Secco S
Int Urol Nephrol. 2026 Aug 8 doi: 10.1007/s11255-026-05335-6.
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care.
Sibona M, Kuang W, Gontero P, Secco S, Cindolo L
Prostate Cancer Prostatic Dis. 2026 Aug 3 doi: 10.1038/s41391-026-01144-1.
Corrigendum to "Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction" [Eur. Urol. 89 (2026) 318-331].
Franco A, Ditonno F, Manfredi C, Bologna E, Licari LC, Orecchia L, Agró EF, Antonelli A, Arlandis S, Autorino R, Tarcan T, Cornu JN, Elterman D, Kaplan S, Lombardo R, McVary K, Secco S, Cindolo L, Nunzio C
Eur Urol. 2026 Aug;90(2):185 doi: 10.1016/j.eururo.2026.05.003.
Italian live Delphi consensus on indications, peri-procedural management, technique, and learning curve of convective water vapor thermal therapy (Rezum™) in men with LUTS/BPH.
Secco S, Greco F, Pierella F, Tuzzolo P, Bevilacqua G, Scarciglia E, Pinto F, Rubilotta E, Cavalleri S, Abatangelo G, Lamon C, Romagnoli D, Fracalanza S, Visalli F, De Luca S, Varvello F, Renzetti R, Annunziata G, Condorelli S, Martinelli E, Marenghi C, Balsamo R, Olivero A, Castellucci R, Sountoulides P, Cindolo L
Urologia. 2026 Aug;93(3):434-440 doi: 10.1177/03915603261440260.
Welcome to the AIS Awards 2023! The event acknowledges the collective efforts of residents, surgeons, healthcare professionals, and the AIS Team in democratizing medical training through online content. With 11 awards across four categories and 45 nominees, the ceremony reflects the remarkable achievements of the AIS Community. Awards are based on real AIS Channel metrics, with two categories determined by audience votes. While celebrating winners, we also recognize the dedication of outstanding surgeons not nominated today. The prizes to be distributed will be as follows: Emerging KOLs Category Most Listened Podcast Most Viewed SOC Most Viewed ACW More Events Held KOL Category More Events Held Most Viewed OOO Live Webinar Category Most Viewed Live Surgery Greatest Social Impact Special Awards Category Best Academic Initiative Congress of the year Surgical Event of the year The virtual gathering provides a unique opportunity for professionals to connect, making the ceremony unforgettable. Join us in honoring the AIS Community's achievements this 2023!
Published
Dec 2023
Published
Dec 2023
Existing therapeutic strategies to treat LUTS due to BPH range from observation and medical treatment to a variety of surgical treatment modalities. TURP has been the treatment method of choice (even if is accompanied by a substantial perioperative morbidity rate and postoperative complications). More recently, transurethral enucleation techniques using different energy sources of laser have become the standard for larger gland sizes. There is significant interest in the development of minimally invasive surgical techniques (MISTs) for LUTS due to BPH that can be performed in an office or ambulatory setting under local anesthesia, ensure rapid and durable symptom relief, and provide a favorable safety profile (avoiding the risk of significant postoperative complications, including the development of anejaculation and/ or sexual dysfunction), as an alternative to traditional TURP or laser enucleation. In this interesting episode of AIS, we will discuss one of the most innovative and efficient MISTs available to treat LUTS due to BPH, the temporary implanted nitinol device, the so-called iTind. We will see how it works, how to properly select a patient, how and where to perform the procedure, and we will review the clinical data available.
With Olympus
Published
Apr 2023
The last decade has seen a significant shift and growth in the surgical options available in the management of symptomatic BPH. Not least driven by patients keen to take up options that avoid a general anaesthetic, that are truly ambulatory, allowing a more rapid return to normal activities but also that avoid the risk of significant post-operative complications, including the development of permanent dry ejaculation and/ or impotence.
With Olympus
Published
Mar 2023
Help your network discover Dr. Silvia Secco's clinical expertise.
